May 15 - 17, 2025 Brasilia - Brazil

Mini Meeting Astrazeneca

SALÃO PANORÂMICO

12 pm – 2 pm

MINI MEETING ASTRAZENECA
Precision medicine: impact of diagnosis on breast cancer treatment

ADVANCES AND CHALLENGES IN BREAST CANCER TREATMENT: PERSPECTIVES IN ENDOCRINE THERAPY, TRIPLE NEGATIVE TUMORS, HER2-LOW AND NEW BIOMARKERS

Speakers:

Target audience: Pathologists, Mastologists and Oncologists

Topics to be discussed through the clinical cases presented:

  • Recent advances in the understanding of endocrine therapy resistance pathways in Breast Cancer, including PI3K/AKT/m-TOR and ESR1.
  • Detailed review of intrinsic subtypes in triple negative tumors, emphasizing the challenges and opportunities in identifying new biomarkers.
  • Relevance of the Her2-low biomarker
  • Innovations in molecular biology and how these advances can be integrated into daily pathology practice to improve the diagnosis, prognosis and treatment of breast cancer.